Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses

Article ID	Journal	Published Year	Pages	File Type
5120798	International Journal of Drug Policy	2017	4 Pages	PDF

Keywords

DAA PWID EASL EFTA European Union people who inject drugs Direct-acting antiviral European Association for the Study of the Liver World Health Organization HCV Hepatitis C virus HIV human immunodeficiency virus WHO

Related Topics

Health Sciences Medicine and Dentistry Psychiatry and Mental Health

Preview

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses

Authors

J.V. Lazarus, K. Safreed-Harmon, S.R. Stumo, M. Jauffret-Roustide, M. Maticic, T. Reic, E. Schatz, J. Tallada, M. Harris, on behalf of the Hep-CORE Study Group on behalf of the Hep-CORE Study Group,